Qlucore, a developer of bioinformatics software, has announced a licence contract with Cambridge Protein Arrays
Qlucore, a provider of bioinformatics visualization and analysis software, has launched the latest version of Qlucore Omics Explorer 3.4.
Qlucore and Nebion have started a collaboration to provide scientists with an end-to-end solution for gene expression analysis, by combining Qlucore Omics Explorer and Genevestigator into a single end to end software package
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.
Qlucore, a provider of bioinformatics visualisation software, has announced the beta version of Qlucore Omics Explorer 3.3. This includes a completely new Next Generation Sequencing (NGS) Module, and range of new functionalities for the base version.
The NGS Module will enable additional functionality related to data generated with NGS technologies which will make it possible to dynamically visualise and analyse NGS data.
As part of its continued expansion into the US market Qlucore has announced the appointment of a new sales manager for the mid-Atlantic region, Beth Repetti.
Qlucore, a developer of bioinformatics software, has announced the launch of the Mac version of Qlucore Omics Explorer 3.1 data analysis software
Qlucore, a leader in the development of bioinformatics software, has announced a partnership with TATAA Biocenter, the world´s premier organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services
As the worlds 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world
In recent years, transcriptomic profiling via next generation sequencing (RNA-seq) has emerged as both a technical and cost-effective alternative to arrays
As not only the HPC industry but the larger computing ecosystem tries to overcome the slowdown and eventual end of transistor scaling described by Moore’s Law, scientists and researchers are implementing programmes that will define the technologies and new materials needed to supplement, or repla
Architectural specialisation is one option to continue to improve performance beyond the limits imposed by the slow down in Moore’s Law.
As the complexity of both HPC hardware and the challenges that scientists are trying to solve using HPC systems increases, ensuring a system is utilised efficiently is necessary to deliver a computing service with value for money and a high research output.
With data rates increasing and more complex challenges arising in life sciences, Panasas’ Jim Donovan and Dale Brantly discuss the benefits of using HPC for these workloads
